78 reports of this reaction
1.1% of all DOXYLAMINE SUCCINATE reports
#20 most reported adverse reaction
DRUG EFFECTIVE FOR UNAPPROVED INDICATION is the #20 most commonly reported adverse reaction for DOXYLAMINE SUCCINATE, manufactured by Chattem, Inc.. There are 78 FDA adverse event reports linking DOXYLAMINE SUCCINATE to DRUG EFFECTIVE FOR UNAPPROVED INDICATION. This represents approximately 1.1% of all 7,212 adverse event reports for this drug.
Patients taking DOXYLAMINE SUCCINATE who experience drug effective for unapproved indication should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG EFFECTIVE FOR UNAPPROVED INDICATION is a less commonly reported adverse event for DOXYLAMINE SUCCINATE, but still significant enough to appear in the safety profile.
In addition to drug effective for unapproved indication, the following adverse reactions have been reported for DOXYLAMINE SUCCINATE:
The following drugs have also been linked to drug effective for unapproved indication in FDA adverse event reports:
DRUG EFFECTIVE FOR UNAPPROVED INDICATION has been reported as an adverse event in 78 FDA reports for DOXYLAMINE SUCCINATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG EFFECTIVE FOR UNAPPROVED INDICATION accounts for approximately 1.1% of all adverse event reports for DOXYLAMINE SUCCINATE, making it a notable side effect.
If you experience drug effective for unapproved indication while taking DOXYLAMINE SUCCINATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.